Authors' reply to the letters concerning the article "Effectiveness of the BNT162b2 vaccine in preventing COVID-19-associated deaths in Poland"

Affiliations

¹ Mazovian Pharmaceutical Chamber, Warsaw, Poland
² Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland
³ Department of Pulmonology, Jagiellonian University Medical College, Kraków, Poland
⁴ Department of Population Health Monitoring and Analysis, National Institute of Public Health NIH-National Research Institute, Warsaw, Poland
⁵ Department of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Lublin, Poland
⁶ Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland. wojciech.szczeklik@uj.edu.pl

Free article

Comment

Łukasz Pietrzak et al. Pol Arch Intern Med. 2023.

Free article

. 2023 Sep 29;133(9):16575.

doi: 10.20452/pamw.16575. Epub 2023 Sep 29.

¹ Mazovian Pharmaceutical Chamber, Warsaw, Poland
² Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland
³ Department of Pulmonology, Jagiellonian University Medical College, Kraków, Poland
⁴ Department of Population Health Monitoring and Analysis, National Institute of Public Health NIH-National Research Institute, Warsaw, Poland
⁵ Department of Virology and Immunology, Institute of Biological Sciences, Maria Curie-Skłodowska University, Lublin, Poland
⁶ Center for Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Kraków, Poland. wojciech.szczeklik@uj.edu.pl

No abstract available

Comment on

Effectiveness of the BNT162b2 (COMIRNATY) vaccination in protecting from death due to COVID-19 in Poland: epidemiologic commentary and limitations.
Jarynowski A. Jarynowski A. Pol Arch Intern Med. 2023 Sep 29;133(9):16574. doi: 10.20452/pamw.16574. Epub 2023 Sep 29. Pol Arch Intern Med. 2023. PMID: 37772713 No abstract available.
Bias in data analysis of the study "Effectiveness of the BNT162b2 vaccine in preventing COVID-19-associated deaths in Poland".
Zagożdżon P. Zagożdżon P. Pol Arch Intern Med. 2023 Sep 29;133(9):16573. doi: 10.20452/pamw.16573. Epub 2023 Sep 29. Pol Arch Intern Med. 2023. PMID: 37772714 No abstract available.